A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer(PANKU-Lung01)
Clinical trial NCT06382116 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06382116
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-22
- Primary completion
- 2026-08-01
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.